West Pharmaceutical Services Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Total Cash from Operations: $536.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $174.4M | 32.5% |
| Other Investing | $5.1M | 1.0% |
| Dividends Paid | $48.1M | 9.0% |
| Stock Repurchases | $115.5M | 21.5% |
| Working Capital | $16.8M | 3.1% |
| Net Cash Flow | $176.4M | 32.9% |